Hims & Hers Health Inc (HIMS) Stock Price, Quote & News

Company Profile

Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides personalized health a...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 415 851 0195

Website: www.hims.com

Address:

2269 Chestnut Street, Suite 523, San Francisco, United States

DadSuggests Mar. 21 at 9:02 PM

$HIMS Next thing to really look forward to is Tuesday when the new official short percentage data is released. More info is always nice to have, and if it has drifted upwards from 40% that will most certainly catch people’s attention.

0 · Reply

unh76 Mar. 21 at 8:02 PM

$HIMS $NVO the real story isn’t just GLP-1, it’s distribution and patient relationships at scale. 2.5M subs is no joke, and that data flywheel can compound if they execute well. The NVO partnership says a lot too. Still early, but feels like there’s something more durable being built here.

0 · Reply

unh76 Mar. 21 at 7:59 PM

$HIMS TD COWEN RAISES $HIMS PRICE TARGET TO $25 FROM $17

0 · Reply

dilhub_fx Mar. 21 at 7:02 PM

$HIMS consumer growth tape looks constructive and steady bids keep the trend story alive

0 · Reply

andreasnewitsch Mar. 21 at 6:55 PM

$HIMS the gap down was not as big as the gap up. Sometimes the downside slide is more gradual. And the upside much more dramatic?

0 · Reply

jdubh22a Mar. 21 at 6:49 PM

$HIMS bullish

0 · Reply

ReversalTrack Mar. 21 at 6:43 PM

JAGU✅ uranium+rare earth play, Keep this high on watch for next week. JAGU sits right in the middle of: •⚛️ Energy crisis (uranium) •🛰️ Defense tech (rare earths) •🌍 Geopolitical supply shift -The world is entering a resource war and most people still don’t see it Critical minerals uranium and rare earths are now essential for defense energy AI and every advanced system the future depend -Uranium and rare earths are needed in the war and in all things needed in the future, and the US will be flooding billions into South America, exactly where jaguar is.JAGU sitting right where the money is going. US pushing billions into critical minerals in Latin America Argentina becoming a key supply hub And JAGU already has exposure there… Rare earth + uranium + IPO reset = serious setup. $IBRX $SLV $GLD $HIMS hot looks also.

0 · Reply

kird Mar. 21 at 6:39 PM

$HIMS almost every recent post is bullish ...not a good sign for bulls.. hopefully the scene changes come next week

0 · Reply

The_Great_Gatsbear Mar. 21 at 6:21 PM

$HIMS - the Peptide power house, that also provides smooth easy access to GLP-1’s among other drugs that people are having a hard time otherwise accessing. The Peptides are what is gonna drive the next generation of humans as personalized peptides will keep us younger for longer, and also healthier overall. ✅- Currently profitable ✅-Building a peptide powerhouse, and will be the personalized peptide power house of the world ✅-is still in the beginning stages of growth $IBRX - currently curing bladder cancer with ANKTIVA with further diagnosis, being added to treatment, and global acceptance picking up steam, but beyond that also as stated in this interview, they are increasing life longevity by increasing your immunity, by increasing your T cells ✅ - currently treating bladder cancer, with world acceptance growing fats ✅ - ANKTIVA use cases growing ✅expected to be at break even in 2H 2026 Both heavily shorted $SPY https://x.com/immunitybio/status/2027875397195473269?s=46

0 · Reply

Motorhhead Mar. 21 at 5:41 PM

$HIMS How is this thing's pump of $BATL working out now? HIMS is bad enough.

0 · Reply

Hims & Hers Health Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Hims & Hers Health, Inc. - HIMS

Mar 18, 2026, 7:00 AM EDT - 3 days ago

UnitedHealth, Hims & Hers, Gambling.Com - Value Investing With Raul Shah

GAMB UNH

Mar 14, 2026, 8:00 AM EDT - 7 days ago

OWL, HIMS, TSLA And More: 5 Stocks Investors Couldn't Stop Buzzing About This Week

TSLA OWL

Mar 12, 2026, 8:35 PM EDT - 8 days ago

Royce Smaller-Companies Growth Fund FY 2025: What Worked

ACVA ALVO AVAV FROG FRPT NVO PAR

Mar 12, 2026, 10:25 AM EDT - 9 days ago

Hims & Hers Health And Novo Nordisk: A Corporate Remarriage That May Work Out Profitably

NVO

Mar 11, 2026, 12:15 PM EDT - 10 days ago

Hims & Hers: The Novo Nordisk Deal Changes Everything

Mar 11, 2026, 10:40 AM EDT - 10 days ago

This Novo Nordisk Partnership Shows That HIMS Has All The Leverage

NVO

Mar 10, 2026, 8:08 PM EDT - 10 days ago

Hims & Hers Names Kathryn Beiser as Chief Communications Officer

Mar 10, 2026, 4:43 PM EDT - 11 days ago

Hims & Hers Health: The GLP-1 Chaos Is Fading, The Thesis Is Still On Track

Mar 10, 2026, 9:00 AM EDT - 11 days ago

Introducing Hims & Hers Benefits, Unlocking Health & Wellness Discounts for Subscribers

Mar 9, 2026, 5:51 PM EDT - 11 days ago

Hims & Hers: Not Selling Yet

Mar 9, 2026, 4:35 PM EDT - 12 days ago

Hims & Hers Health: The Juice Is Worth The Squeeze

Mar 9, 2026, 3:23 PM EDT - 12 days ago

Stock Of The Day: Will Hims & Hers Go Into Another Short Squeeze?

Mar 9, 2026, 1:27 PM EDT - 12 days ago

Hims & Hers stock: why today's gains are unlikely to be sustainable

Mar 9, 2026, 12:46 PM EDT - 12 days ago

Hims & Hers Health Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Hims & Hers Health, Inc. - HIMS

Mar 9, 2026, 11:27 AM EDT - 12 days ago

Hims & Hers stock price is surging today. A surprising deal with Novo Nordisk is the reason why

NVO

Mar 9, 2026, 11:00 AM EDT - 12 days ago

HIMS Skyrockets on Reported Deal with NVO to Sell GLP-1s

NVO

Mar 9, 2026, 10:38 AM EDT - 12 days ago

Novo Nordisk drops Him & Hers lawsuit

NVO

Mar 9, 2026, 10:32 AM EDT - 12 days ago

Hims & Hers Stock Pops on a Deal With Rival Novo Nordisk—What You Need to Know

Mar 9, 2026, 9:23 AM EDT - 12 days ago

Hims stock jumps 50% as Novo Nordisk ends lawsuit, strikes deal

Mar 9, 2026, 8:52 AM EDT - 12 days ago

Hims & Hers shares surge 50% after Novo Nordisk ends legal feud over compounded weight loss drugs

NVO

Mar 9, 2026, 8:35 AM EDT - 12 days ago

What's Happening With HIMS Stock?

Mar 9, 2026, 8:33 AM EDT - 12 days ago

Novo Nordisk strikes deal for Hims to sell Wegovy and Ozempic, drops lawsuit

NVO

Mar 9, 2026, 8:30 AM EDT - 12 days ago

Hims & Hers Announces Strategic Shift for US Weight Loss Business

Mar 9, 2026, 7:04 AM EDT - 12 days ago

Hims & Hers, Novo Nordisk Weight-Loss Drug Deal Ends Legal Feud, Stock Soars

NVO

Mar 9, 2026, 6:33 AM EDT - 12 days ago

Hims shares jump after report of Novo Nordisk partnership that may end legal feud

NVO

Mar 9, 2026, 6:33 AM EDT - 12 days ago

Hims & Hers Stock Soars 54%. It's Struck a Truce With Novo Nordisk, Report Says.

NVO

Mar 9, 2026, 6:06 AM EDT - 12 days ago

Hims & Hers Shares Double on Report of Wegovy Tie-Up

Mar 9, 2026, 5:45 AM EDT - 12 days ago

Hims & Hers stock rockets on reported end to Novo Nordisk weight-loss drug dispute

NVO

Mar 6, 2026, 8:04 PM EST - 14 days ago

Novo and Hims resolve dispute, will sell obesity drugs together, Bloomberg News reports

NVO

Mar 5, 2026, 3:19 PM EST - 16 days ago

YieldMax® HIMS Option Income Strategy ETF (HIYY) Trading Halt

Mar 3, 2026, 10:57 AM EST - 18 days ago

Hims & Hers Health: Leaving GLP-1s Behind

Mar 3, 2026, 10:40 AM EST - 18 days ago

Hims' pharmacy partner will reintroduce GLP-1 pill pulled from market, Endpoints News reports

Mar 2, 2026, 8:17 PM EST - 18 days ago

Hims & Hers Health, Inc. (HIMS) Presents at Morgan Stanley Technology, Media & Telecom Conference 2026 Transcript

Mar 2, 2026, 2:28 PM EST - 19 days ago

Carillon Eagle Small Cap Growth Fund Q4 2025 Portfolio Review

BE BTSG COHR ESTA GH ITRI PRKS

Mar 2, 2026, 12:00 PM EST - 19 days ago

Glancy Prongay Wolke & Rotter LLP Announces Investigation of Hims & Hers Health, Inc. (HIMS) on Behalf of Investors

Mar 2, 2026, 9:16 AM EST - 19 days ago

Hims expansion may not come in time for risky GLP-1 business

Mar 1, 2026, 4:00 PM EST - 20 days ago

HIMS Core Business Faces Challenges in Guidance, GLP-1 Prices & NVO

Feb 27, 2026, 12:00 PM EST - 22 days ago

Law Offices of Howard G. Smith Announces Investigation of Hims & Hers Health, Inc. (HIMS) on Behalf of Investors

Feb 25, 2026, 7:18 PM EST - 23 days ago

The Law Offices of Frank R. Cruz Announces Investigation of Hims & Hers Health, Inc. (HIMS) on Behalf of Investors

Feb 25, 2026, 11:07 AM EST - 24 days ago

Hims & Hers Health: The GLP-1 Party Is Over

Feb 24, 2026, 4:02 PM EST - 25 days ago

Hims & Hers Health: Don't Get Lost In The Weeds

Feb 24, 2026, 2:30 PM EST - 25 days ago

Hims & Hers Health: Great Vision, Now On Sale -- Here's Why I'm Upgrading

Feb 24, 2026, 12:46 PM EST - 25 days ago

Hims & Hers Health Analysts Cut Their Forecasts After Q4 Results

Feb 24, 2026, 10:30 AM EST - 25 days ago

KDP Beats & HIMS Misses Sales, QCOM Gains on Upgrades

QCOM KDP

Feb 24, 2026, 8:47 AM EST - 25 days ago

Hims & Hers Health After The GLP-1 Collapse

Feb 24, 2026, 8:32 AM EST - 25 days ago

Hims & Hers Stock Stumbles - Cautions About Pressure Due To Super Bowl Ad, Change In Shipping Cadences

Feb 24, 2026, 6:40 AM EST - 25 days ago

Wall Street Breakfast Podcast: FedEx Demands Tariffs Return To Sender

COST FDX IBM

Feb 24, 2026, 6:30 AM EST - 25 days ago

Hims & Hers Q4 Earnings Show Growth Amid GLP-1 Scrutiny

Feb 23, 2026, 9:25 PM EST - 25 days ago

Hims & Hers Health, Inc. (HIMS) Q4 2025 Earnings Call Transcript

DadSuggests Mar. 21 at 9:02 PM

0 · Reply

unh76 Mar. 21 at 8:02 PM

0 · Reply

unh76 Mar. 21 at 7:59 PM

$HIMS TD COWEN RAISES $HIMS PRICE TARGET TO $25 FROM $17

0 · Reply

dilhub_fx Mar. 21 at 7:02 PM

$HIMS consumer growth tape looks constructive and steady bids keep the trend story alive

0 · Reply

andreasnewitsch Mar. 21 at 6:55 PM

$HIMS the gap down was not as big as the gap up. Sometimes the downside slide is more gradual. And the upside much more dramatic?

0 · Reply

jdubh22a Mar. 21 at 6:49 PM

$HIMS bullish

0 · Reply

ReversalTrack Mar. 21 at 6:43 PM

0 · Reply

kird Mar. 21 at 6:39 PM

$HIMS almost every recent post is bullish ...not a good sign for bulls.. hopefully the scene changes come next week

0 · Reply

The_Great_Gatsbear Mar. 21 at 6:21 PM

0 · Reply

Motorhhead Mar. 21 at 5:41 PM

$HIMS How is this thing's pump of $BATL working out now? HIMS is bad enough.

0 · Reply

andreasnewitsch Mar. 21 at 5:36 PM

$HIMS even gold is down more than 10%

0 · Reply

earlthompson7 Mar. 21 at 4:25 PM

Everyone is analyzing $HIMS as a GLP-1 story. That’s like analyzing Amazon as a bookstore in 2005. $HIMS has 2.5M subscribers, behavioral health data across sexual health, hair loss, dermatology, weight loss, hormone therapy, labs, and now cancer screening. $NVO, a $400B pharma giant, looked at the entire US healthcare landscape and chose $HIMS as their direct distribution platform. They didn’t want to do that because $HIMS compounds drugs. They still did it because $HIMS owns the patient relationship at scale. That’s the moat that is compounding with every new customer and data point $HIMS gains.

0 · Reply

Solidgainz2023 Mar. 21 at 3:10 PM

$HIMS Im fairly new to this stock. Ive seen that were hoping for peptides for be legalized by Kennedy. Is there any other near term new were hoping for? Besides end of war

2 · Reply

Solidgainz2023 Mar. 21 at 3:08 PM

$HIMS With 86% of the shares owned by institutions and the company buyjng shares. If institutions see this as a buying opportunity and load up we coukd see always all the sames owned and not trading. What happens when 95% of shares are locked down held long term by Institutions and 50% of shares are short? If retail would get more involved in this we'd see $100 just dreaming...

0 · Reply

Solidgainz2023 Mar. 21 at 3:03 PM

$HIMS Good companys to short are unprofitable companys because they continuously sell more shares to stay alive they continuously dillute the float. This company is profitable and buying back shares thats the opposite. So, whats the bear thesis again?

2 · Reply